Stellar names Tessie Che to board
This article was originally published in Scrip
Executive Summary
Stellar Biotechnologies, which develops keyhole limpet hemocyanin (KLH), an immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets, has named Dr Tessie Che to its board of directors. Dr Che is currently chair of the board of privately held Amaran Biotechnology, based in Taiwan. She also co-founded Optimer Pharmaceuticals in 1998, and served as chief operating officer and senior vice-president of corporate affairs at the company.